1. Home
  2. AMBO vs INM Comparison

AMBO vs INM Comparison

Compare AMBO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

N/A

Current Price

$1.84

Market Cap

5.9M

Sector

Real Estate

ML Signal

N/A

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

SELL

Current Price

$1.36

Market Cap

7.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AMBO
INM
Founded
2000
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
7.1M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
AMBO
INM
Price
$1.84
$1.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.9K
★ 57.4K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 337.04
62.68
EPS
★ 0.00
N/A
Revenue
★ $9,469,000.00
$4,942,633.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.00
P/E Ratio
$377.55
★ N/A
Revenue Growth
0.82
★ 7.50
52 Week Low
$1.47
$0.58
52 Week High
$5.40
$2.33

Technical Indicators

Market Signals
Indicator
AMBO
INM
Relative Strength Index (RSI) 35.97 52.35
Support Level $1.69 $1.35
Resistance Level $2.19 $1.40
Average True Range (ATR) 0.06 0.05
MACD -0.02 0.00
Stochastic Oscillator 7.04 45.83

Price Performance

Historical Comparison
AMBO
INM

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Share on Social Networks: